Biopharmaceutical services organization Parexel International has named Peter Steiger, PhD, to the newly created position of vice president and chief scientific officer for medical imaging.
Steiger comes to the post with more than 25 years of experience in applying specialized medical imaging techniques in support of biopharmaceutical product development, and he will oversee worldwide medical imaging scientific strategy at Parexel Informatics, according to the firm.
Prior to joining Parexel, Steiger was CEO of Optasia Medical from 2006 to 2013 and CEO of Synarc from 2000 to 2005. He also spent several years as chief scientist for women's imaging vendor Hologic, where he led the medical data management division responsible for supporting the use of bone densitometry measurements in clinical studies.
